1. Home
  2. Live Updates
  3. Linical testing

Live Breaking News & Updates on Linical testing

Stay informed with the latest breaking news from Linical testing on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Linical testing and stay connected to the pulse of your community

COVID in Boise wastewater is highest it's been in 2 years. This is what to know.

A new COVID-19 variant is responsible for over half of infections in Boise, wastewater data shows of latest surge.

Boise , Idaho , United-states , Garden-city , David-pate , National-wastewater-surveillance-system , Hampikian-lab-at-boise-state-university , Luke-health-system , Wastewater-surveillance-system , Idaho-statesman , Health-system , Lander-street

Itchy skin? Possible atopic dermatitis? Lavender essential oil might be just what you're looking for

Researchers demonstrate that lavender essential oils, particularly linalyl acetate, effectively suppress atopic dermatitis without skin sensitization, offering a natural, accessible treatment option.

United-states , Drug-administration , Stimulation-index , Atopic-dermatitis , Ermatitis , Kin , Ir-pollution , Nti-inflammatory , Ssay , Ell , Ell-line

Cancer Cachexia Market to Hit USD 3.6 billion by 2031, at a CAGR 4.7% | Says Transparency Market Research, Inc.

Progress in the market is also being aided by an increase in research on non-steroidal anti-inflammatory drugs (NSAIDs) and a rise in patient knowledge of the advantages of drugs.Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cancer cachexia market was projected to attain US$ 2.2 billion in 2022. It is anticipated to garner a 4.7% CAGR from 2023 to 2031. By 2031, the market is likely to attain US$ 3.6 billion by 2031. Researc

Canada , Delaware , United-states , Switzerland , Japan , America , American , Asia-pacific , Eli-lilly , Nikhil-sawlani , Aphios-corporation , Helsinn-group

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm's INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH).

Lily-ramsey , Tomasz-kostrzewski , Cn-bio-contract-research-services , Contract-research-services , Chief-scientific , Chip , Linical-testing , Iver , Iver-disease , Ssay , Iopharmaceutical , Fficacy

Researchers pioneer a novel treatment for the most common autoimmune encephalitis

Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

Berlin , Germany , Momsen-reincke , Danielle-ellis , Brain , Ntibodies , Ntibody , Lood , Rain-disease , Ell , Linical-testing

Science, Innovation, and Xenotransplantation: A Discussion with Dr. Wenning Qin

In this interview, we delve deep into the pioneering world of xenotransplantation and the evolving landscape of gene editing.

Jennifer-doudna , Mario-capecchi , Martin-evans , Lily-ramsey , Wenning-qin , Oliver-smithies , Emmanuelle-charpentier , David-tadevosian-shutterstock , Biogen-inc , Southern-illinois-university , Washington-university-school-of-medicine

Eurofins' Core Business Organic Growth Momentum Improves in Q3 2023 to 7.6%

LUXEMBOURG, October 24, 2023--Regulatory News: Eurofins Scientific SE (Paris:ERF):

United-kingdom , Luxembourg , United-states , New-zealand , Australia , India , America , Gilles-martin , Diagnostics-center-peekaboo , Group-core-business , Euronext-paris-stock-exchange , Biopharma-services

The Skanner News - Breast Cancer Is Deadlier for Black Women. A Study of Mammograms Could Help Close the Gap

The underrepresentation of women and minorities in research is a long-simmering issue affecting many health problems. Trials without diversity lead to gaps in understanding of how new treatments work for all people.

Washington , District-of-columbia , United-states , University-of-north-carolina , North-carolina , Canada , Argentina , Peru , Italy , Georgetown-university , South-korea , Thailand

Zuranolone is a huge triumph for PPD—but it could negatively impact women's health research

The first-ever FDA-approved pill for postpartum depression is a landmark achievement, but it could come at a high cost for women in more ways than one.

Sage-therapeutics , Sage-therapeutic , Womens-health , Linical-depression , Linical-research , Ostpartum-depression , Da , Uranolone , Ormone-imbalance , Llopregnanolone , Ewly-approved-drug

Further investment for BDD Pharma after £2M funding

Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a £2 million ($1.3 million) investment.

United-kingdom , British , Carol-thomson , British-business-bank , Thomson , Scottish-enterprise , British-business , Life-sci , Archangel-investors , Markets-amp-regulations , Linical-development , Atient-centricity